Torsades de Pointes — Magnesium and Overdrive Pacing

Key Points

• Torsades is polymorphic VT occurring in the setting of prolonged ventricular repolarization.
• Unstable or pulseless torsades requires immediate unsynchronized defibrillation.
• Give IV magnesium even if the serum magnesium level is normal.
• Correct potassium to the high-normal range and correct other electrolyte abnormalities.
• Stop QT-prolonging medications and identify interacting drugs.
• Recurrent acquired torsades may require overdrive pacing or selected use of isoproterenol.
• Avoid QT-prolonging antiarrhythmics in torsades.
• Do not assume all polymorphic VT is torsades; acute ischemic polymorphic VT can occur with a normal QT.

Algorithm

1. Assess pulse and hemodynamic stability during polymorphic VT.
2. If pulseless or unstable, deliver immediate unsynchronized shock and follow resuscitation protocol.
3. Review QT interval and clinical context to determine whether the rhythm is torsades.
4. Give IV magnesium sulfate and correct potassium, magnesium, and calcium abnormalities.
5. Stop nonessential QT-prolonging medications and treat overdose or drug interactions.
6. For recurrent pause-dependent acquired torsades, increase heart rate with overdrive pacing or selected isoproterenol use.
7. Evaluate ischemia when QT is normal or ACS features are present.
8. After stabilization, assess for congenital long-QT syndrome and arrange electrophysiology follow-up.

Clinical Synopsis & Reasoning

Torsades de pointes is a form of polymorphic ventricular tachycardia in which the QRS complexes appear to twist around the baseline and the underlying QT interval is prolonged. It often begins after a pause or long-short sequence and may terminate spontaneously, recur repeatedly, or degenerate into ventricular fibrillation. Patients can present with palpitations, presyncope, syncope, seizure-like activity from cerebral hypoperfusion, or cardiac arrest.

The key reasoning step is to separate torsades from polymorphic VT caused by acute ischemia with a normal QT. Magnesium and rate acceleration are central for torsades, whereas ischemic polymorphic VT requires urgent treatment of ischemia and does not necessarily benefit from the same preventive strategy. Measure QTc on a sinus-rhythm or post-conversion ECG and review prior tracings when available.

Acquired QT prolongation is common and frequently multifactorial. Culprits include antiarrhythmics, antipsychotics, antidepressants, methadone, some antiemetics, antimicrobial agents, and drug interactions that raise concentrations. Hypokalemia and hypomagnesemia amplify risk. Bradycardia, high-grade AV block, starvation, severe illness, and female sex are additional risk factors. Congenital long-QT syndrome should be considered in younger patients, recurrent unexplained syncope, exercise- or emotion-triggered events, or a family history of sudden death.

A single automatically calculated QTc can be misleading, particularly during tachycardia or with abnormal QRS duration. Review the tracing manually and consider correction formula limitations. Clinical treatment should not wait for perfect QT measurement when recurrent polymorphic VT is occurring.

Treatment Strategy & Disposition

If torsades is sustained with hemodynamic instability or there is no pulse, deliver an immediate unsynchronized high-energy shock because synchronization is unreliable in polymorphic VT. Follow the cardiac arrest algorithm when pulseless. Brief self-terminating episodes still require urgent prevention because recurrence can progress to VF.

Give IV magnesium sulfate even when the measured magnesium concentration is normal. A commonly used adult dose is 2 g IV, administered promptly and repeated or followed by infusion depending on recurrence and local protocol. Magnesium suppresses early afterdepolarizations but does not reliably shorten the QT interval. Correct potassium aggressively toward the high-normal range and correct hypocalcemia or hypomagnesemia when present. Stop all nonessential QT-prolonging medications and address drug interactions.

For recurrent acquired pause-dependent torsades despite magnesium and electrolyte correction, increase the heart rate. Temporary transvenous overdrive pacing is effective and often targets a rate sufficient to prevent long pauses. Isoproterenol can be used as a bridge in selected acquired long-QT cases when pacing is not immediately available, but it is generally avoided in congenital long-QT syndrome and in ischemia because adrenergic stimulation can be harmful. Treat bradycardia or AV block directly.

Avoid antiarrhythmics that further prolong repolarization, including many class IA and class III drugs, in true torsades. Lidocaine may have a role in selected refractory cases under expert guidance because it does not prolong QT. Patients with suspected congenital long-QT syndrome require cardiology/electrophysiology evaluation, medication review, family risk assessment, and consideration of beta-blocker or ICD therapy based on syndrome and event severity.

Epidemiology / Risk Factors

• Acquired drug-related QT prolongation is more common than congenital long-QT syndrome in adult emergency practice.
• Risk rises with multiple QT-prolonging drugs, female sex, electrolyte depletion, renal or liver dysfunction, and bradycardia.
• Congenital long-QT syndromes can present with exertional or emotion-triggered syncope or sudden death.
• Torsades episodes can be brief and self-terminating before a more malignant recurrence.
• Hospitalized patients receiving multiple medications are an important preventable-risk population.

Investigations

Rescue Options at a Glance

Pharmacology

Prognosis / Complications

• Prompt defibrillation is highly effective for an unstable episode, but recurrence remains a risk until the substrate is corrected.
• Drug-induced torsades usually has a good prognosis when the culprit is removed and electrolytes are normalized.
• Untreated recurrent torsades can degenerate into VF and sudden death.
• Congenital long-QT syndrome carries lifelong recurrence risk and may require beta-blockers, left cardiac sympathetic denervation, or ICD therapy in selected patients.
• Recognition of the causative medication prevents repeat exposure.

Patient Education / Counseling

• Provide a written list of QT-prolonging drugs to avoid or review with clinicians and pharmacists.
• Explain the importance of maintaining potassium and magnesium during vomiting, diarrhea, or diuretic therapy.
• Seek emergency care for syncope, recurrent palpitations, or seizure-like episodes.
• Patients with suspected congenital long-QT syndrome should avoid unsupervised intense exercise until specialist assessment.
• Family screening may be recommended when congenital long-QT syndrome is diagnosed.
• Tell every future prescriber about a prior torsades episode.

Notes

The word torsades should be reserved for polymorphic VT with prolonged repolarization. This matters because the recurrence-prevention plan changes when polymorphic VT is driven by acute ischemia with a normal QT. Both may require shock when unstable, but magnesium, rate acceleration, and removal of QT-prolonging drugs are specifically central to torsades.

Medication reconciliation is often the definitive treatment. The dangerous combination is frequently not one dramatic overdose but several modest risk factors: a QT-prolonging medication, vomiting with hypokalemia, renal dysfunction that raises drug concentration, and bradycardia. Correcting all contributors is more effective than focusing on magnesium alone.

References

1. American Heart Association 2025 Adult Advanced Life Support — Link
2. AHA 2025 Special Circumstances of Resuscitation — Link